You are here

AusPAR: Larotrectinib

Related information


How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

21 December 2020
AusPAR Details
AusPAR
Active Ingredient
Larotrectinib
Product Name
Vitrakvi
Sponsor
Bayer Australia Limited
Submission Number
PM-2019-02585-1-5
Submission Type
New chemical entity
Decision
Approved for provisional registration
AusPAR Date
16 December 2020
Publication Date

21 December 2020